Respiratory distress is the single most important cause of mortality and morbidity in preterm infants and is caused by a deficiency of lung surfactant.

SAN DIEGO, CA, USA, May 22, 2019 /⁨EINPresswire.com⁩/ — KAER Biotherapeutics has received a …
KAER Biotherapeutics Awarded NIH Grant to develop SUPRAER® Surfactant Aerosol Therapy for Neonatal Respiratory Distress